In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk

John F Cox 3rd

doi:10.7326/J22-0059

In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk

Ann Intern Med. 2022 Aug;175(8):JC91. doi: 10.7326/J22-0059. Epub 2022 Aug 2.

Author

John F Cox 3rd¹

Affiliation

¹ University of Rochester School of Medicine, Rochester, New York, USA (J.F.I.).

PMID: 35914257
DOI: 10.7326/J22-0059

Abstract

Carbone F, Van den Houte K, Besard L, et al. Diet or medication in primary care patients with IBS: the DOMINO study-a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute. Gut. 2022. [Epub ahead of print]. 35483886.

Publication types

Comment

MeSH terms

Diet
Diet, Carbohydrate-Restricted
Humans
Irritable Bowel Syndrome* / diagnosis
Irritable Bowel Syndrome* / drug therapy
Quaternary Ammonium Compounds
Self-Management*
Smartphone*

Substances

Quaternary Ammonium Compounds
octylonium